However, when adjusted for tumour grade, the lower hazard of death for patients with ALT−/Tel− tumours vs those with ALT-positive tumours became only suggestive of statistical significance (hazard ratio (HR), 0.15; 95% CL, 0.016–1.48, P=0.09). The gene discussed is GPT; the disease is neoplasm.